Press Release: European Medicines Agency reaffirms efficacy and safety of H1N1 pandemic vaccines

The European Medicines Agency (EMEA), on 20 November 2009, announced that it had reviewed further data on the centrally authorised pandemic vaccines, Celvapan, Focetria and Pandemrix. The Agency reaffirmed their positive balance of benefits and risks in the context of the current H1N1 influenza pandemic.

• Primary Source